As regulators review Kaiser Permanente’s proposed acquisition of a respected health system based in Pennsylvania, health care experts are still puzzling over how the surprise deal, announced in April, could fulfill the managed care giant’s promise of improving care and reducing costs for patients, including in its home state of California.
Neuroprotector Hopeful in Stroke; Late-Pandemic STEMIs; Exercise vs Risky Carotids?
In the CLEAR Outcomes trial, bempedoic acid (Nexletol) reduced cardiac events to a similar extent as statins, according to a secondary analysis presented at ENDO
June 21, 2023